Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BRTX
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202422h15GlobeNewswire Inc.BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:BRTXBioRestorative Therapies Inc
30/04/202413h30GlobeNewswire Inc.BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics TechnologyNASDAQ:BRTXBioRestorative Therapies Inc
16/04/202416h25AllPennyStocks.comBiotech Catches Major Premarket Bid Following FDA ClearanceNASDAQ:BRTXBioRestorative Therapies Inc
16/04/202413h45GlobeNewswire Inc.BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentNASDAQ:BRTXBioRestorative Therapies Inc
08/04/202413h45GlobeNewswire Inc.BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
03/04/202422h38GlobeNewswire Inc.BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued WarrantsNASDAQ:BRTXBioRestorative Therapies Inc
01/04/202413h45GlobeNewswire Inc.BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-KNASDAQ:BRTXBioRestorative Therapies Inc
11/03/202421h15GlobeNewswire Inc.BioRestorative Therapies to Participate in the 36th Annual ROTH ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
06/03/202422h34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
14/02/202419h44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
12/02/202415h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
09/02/202414h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
08/02/202422h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
06/02/202414h05GlobeNewswire Inc.BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-MarketNASDAQ:BRTXBioRestorative Therapies Inc
05/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
05/02/202413h30GlobeNewswire Inc.BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
01/02/202422h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
01/02/202413h30GlobeNewswire Inc.BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual MeetingNASDAQ:BRTXBioRestorative Therapies Inc
12/12/202315h15GlobeNewswire Inc.BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity ProgramNASDAQ:BRTXBioRestorative Therapies Inc
05/12/202322h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
01/12/202323h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:BRTX